Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
545,872,779
-
Shares change
-
+45,555,957
-
Total reported value, excl. options
-
$6,375,349,918
-
Value change
-
+$537,705,852
-
Put/Call ratio
-
41%
-
Number of buys
-
136
-
Number of sells
-
-73
-
Price
-
$11.68
Significant Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q3 2023
245 filings reported holding ROIV - Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share as of Q3 2023.
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 545,872,779 shares
of 695,088,397 outstanding shares and own 79% of the company stock.
Largest 10 shareholders include QVT Financial LP (112,541,536 shares), VIKING GLOBAL INVESTORS LP (73,434,301 shares), SB INVESTMENT ADVISERS (UK) LTD (73,031,667 shares), FMR LLC (38,910,625 shares), MORGAN STANLEY (19,311,631 shares), BlackRock Inc. (17,723,537 shares), WELLINGTON MANAGEMENT GROUP LLP (14,842,976 shares), Patient Square Capital LP (12,639,920 shares), BAKER BROS. ADVISORS LP (11,877,171 shares), and T. Rowe Price Investment Management, Inc. (10,649,397 shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.